Y-mAbs Therapeutics (YMAB)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	68.12 mm	68.12 mm	68.12 mm	68.12 mm	68.12 mm	68.12 mm
Cash burn (monthly)	2.54 mm	1.65 mm	2.86 mm	2.20 mm	82.33 k	1.09 mm
Cash used (since last report)	7.12 mm	4.62 mm	8.00 mm	6.17 mm	230.64 k	3.06 mm
Cash remaining	61.00 mm	63.50 mm	60.12 mm	61.95 mm	67.89 mm	65.06 mm
Runway (months of cash)	24.0	38.5	21.1	28.1	824.6	59.6

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q2 2024

YMAB institutional ownership history Ownership history

82.3% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	99	84	+17.9%
Opened positions	28	15	+86.7%
Closed positions	13	24	-45.8%
Increased positions	30	20	+50.0%
Reduced positions	28	38	-26.3%

13F shares	Current	Prev Q	Change
Total value	289.84 bn	301.52 bn	-3.9%
Total shares	35.89 mm	30.92 mm	+16.1%
Total puts	300.00	27.00 k	-98.9%
Total calls	19.40 k	26.80 k	-27.6%
Total put/call ratio	0.0	1.0	-98.5%

Largest owners	Shares	Value	Change
Biotech ApS WG	4.18 mm	$130.58 mm	0.0%
Paradigm Biocapital Advisors	3.87 mm	$46.76 bn	+73.3%
HBM Healthcare Investments	3.81 mm	$0.00	0.0%
BLK BlackRock	2.94 mm	$35.50 bn	+2.9%
Sofinnova Investments	2.19 mm	$26.51 bn	0.0%
Sofinnova Venture Partners X	2.19 mm	$52.07 mm	0.0%
Vanguard	1.96 mm	$23.64 bn	-5.4%
Polar Capital	1.83 mm	$22.12 bn	0.0%
Cormorant Asset Management	1.45 mm	$17.52 bn	NEW
Acorn Bioventures	1.35 mm	$4.55 mm	0.0%

Largest transactions	Shares	Bought/sold	Change
Paradigm Biocapital Advisors	3.87 mm	+1.64 mm	+73.3%
Cormorant Asset Management	1.45 mm	+1.45 mm	NEW
D. E. Shaw & Co.	926.46 k	+926.46 k	NEW
Point72 Asset Management	358.95 k	+358.95 k	NEW
Millennium Management	349.78 k	+349.78 k	NEW
Acadian Asset Management	323.18 k	-279.14 k	-46.3%
Citadel Advisors	261.74 k	+261.74 k	NEW
Charles Schwab Investment Management	255.60 k	+255.60 k	NEW
GS The Goldman Sachs Group, Inc.	138.74 k	-226.80 k	-62.0%
Nuveen Asset Management	112.48 k	-155.25 k	-58.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

YMAB insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
19 Sep 24	Thomas Gad	Common Stock	Option exercise	Acquire M	No	No	4.38	22,831	100.00 k	181,531
19 Sep 24	Thomas Gad	Employee Stock Option Common Stock	Option exercise	Dispose M	No	No	4.38	22,831	100.00 k	143,169
16 Sep 24	Thomas Gad	Common Stock	Sell	Dispose S	Yes	No	12.97	30,000	389.10 k	67,681
13 Sep 24	Thomas Gad	Common Stock	Sell	Dispose S	Yes	No	13.47	65,000	875.55 k	97,681
28 Aug 24	Torben Lund-Hansen	Common Stock	Sell	Dispose S	No	No	15.37	50,000	768.50 k	35,600
28 Aug 24	Torben Lund-Hansen	Common Stock	Option exercise	Acquire M	No	No	4.38	50,000	219.00 k	85,600
28 Aug 24	Torben Lund-Hansen	Employee Stock Option Common Stock	Option exercise	Dispose M	No	No	4.38	50,000	219.00 k	100,000
26 Aug 24	Joris Wilms	Common Stock	Sell	Dispose S	No	No	14.69	5,000	73.45 k	30,600
12 Jul 24	Pfreundschuh Peter P.	Common Stock	Grant	Acquire A	No	No	0	46,000	0.00	46,000
12 Jul 24	Pfreundschuh Peter P.	Employee Stock Option Common Stock	Grant	Acquire A	No	No	12.47	170,000	2.12 mm	170,000